Drug-maker wraps up CBCA recapitalisation plan
Canada (Credit: istock.com/kodda)
Canadian drug maker Concordia has completed a year-long out-of-court restructuring plan under the Canada Business Corporations Act.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.
Subscribe now